Pertussis in rural populations of Saskatchewan (1995 to 2003): Incidence, seasonality, and differences among cases

Canadian Journal of Public Health

Volumn 97, Issue 6, 2006, Pages 459-464

  Vickers, David ^b,c   Mainar Jaime, Raúl C ^b,c   Pahwa, Punam ^a,c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Epidemiology; Pertussis; Rural communities; Surveillance; Vaccination

Indexed keywords

ACELLULAR VACCINE; PENTA; PENTACEL; PERTUSSIS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANADA; CHILD; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; HUMAN; INCIDENCE; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; RURAL POPULATION; SEASONAL VARIATION; URBAN RURAL DIFFERENCE; VACCINATION;

EID: 33845487695     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405228     Document Type: Article

References (31)

1. Broutin H, Guegan JF, Elguero E, Simondon F, Cazelles B. Large-scale comparative analysis of pertussis population dynamics: Periodicity, synchrony, and impact of vaccination. Am J Epidemiol 2005;161:1159-67.
2. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press, 1991.
3. Pitblado R, Pong R, Irvine A, Nagarajan K, Sahai V. Assessing rural health: Toward developing health indicators for rural Canada. Centre for Rural and Northern Research, Laurentian University, 1999.
4. Schuman SH. Agromedicine and emerging infectious diseases. J Agromed 2001;8:19-26.
5. 1 community profiles. Statistics Canada (Ottawa, ON), 2004. Available online at: http://www12.statcan.ca/english/profi101/PlaceSearchForm1.cfm (Accessed June 27, 2005).
6. Mortimer EA, Cherry JD. Pertussis (whooping cough). In: Gershon AA, Hotez PJ, Katz SL (Eds.), Krugman's Infectious Diseases of Children. Philadelphia, PA: Mosby, 2004;443-59.
7. Tilley PA, Kanchana MV, Knight I, Blondeau J, Antonishyn N, Deneer H. Detection of Bordetella pertussis in a clinical laboratory by culture, polymerase chain reaction, and direct fluorescent antibody staining; accuracy, and cost. Diag Microbiol Infect Dis 2000;37:17-23.
8. Gordis L. Measuring the occurrence of disease. In: Epidemiology, Second Edition. Philadelphia, PA: W.B. Saunders Company, 2000;31-62.
9. Halperin S, Scheifele D, Barreto L, Pim C, Guasparini R, Medd L, et al. Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age. Pediatr Infect Dis J 1999;21;772-79.
10. Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, et al. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics 1997;100:772-88.
11. Langue J, Matisse N, Pacoret P, Undreiner F, Boisnard F, Soubeyrand B, et al. Persistence of antibodies at 5-6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: Immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5-6 years of age. Vaccine 2004;22:1406-14.
12. Nelson KE, Williams CM, Graham NMH. Surveillance. In: Infectious Disease Epidemiology, First Edition. Gaithersburg: Aspen, 2001;97-118.
13. Geisecke J. Routine surveillance of infectious diseases. In: Modern Infectious Disease Epidemiology, First Edition. London: Arnold, 2002;148-60.
14. Kinsley C. Challenges in rural, remote, northern and Aboriginal communities. In: Rural Health in Rural Hands: Strategic Directions for Rural, Remote, Northern and Aboriginal Communities. Ottawa: The Commission, Ministerial Advisory Council on Rural Health: Health Canada, 2002;9-16.
15. Stokley S, Smith PJ, Mevens RM, Battaglia MP. Vaccination status of children living in rural areas in the United States: Are they protected? Am J Prev Med 2001;20(4 Suppl):55-60.
16. Steyer TE, Mainous AG 3rd, Geesey ME. The effect of race and residence on the receipt of childhood immunizations: 1993-2001. Vaccine 2005;23(12):1464-70.
17. Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, Macnabb J, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002;185:1448-53.
18. Broutin H, Rohani P, Guegan JF, Grenfell BT, Simondon F. Loss of immunity to pertussis in a rural community in Senegal. Vaccine 2004;22:594-96.
19. Lacombe K, Yam A, Simondon K, Pinchinat S, Simondon F. Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children. Vaccine 2004;23:623-28.
20. Forsyth KD, Campins-Marti M, Caro J, Cherry JD, Greenberg D, Guiso N, et al. New pertussis vaccination strategies beyond infancy: Recommendations by the Global Pertussis Initiative. Clin Infect Dis 2004;39:1802-9.
21. Simondon F, Preziosi MP, Yam A, Kane CT, Chabirand L, Iteman I, et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 1997;15:1606-12.
22. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors p.69/pertactin and pertussis toxin in the Netherlands: Temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998;66:670-75.
23. van Boven M, de Melker HE, Schellekens JFP, Kretzschmar M. A model based evaluation of the 1996-7 pertussis epidemic in the Netherlands. Epidemiol Infect 2001;127:73-85.
24. Mäkinen J, Mertsola J, Mooi FR, Van Amersfoorth S, Arvilommi H, Viljanen MK, et al. Bordetella pertussis isolates, Finland. Emerg Infect Dis 2005;11:183-84.
25. Tsang RS, Lau AK, Sill ML, Halperin SA, Van Caeseele P, Jamieson F, et al. Polymorphisms of he fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol 2004;42:5364-67.
26. Peppler MS, Kuny S, Nevesinjac A, Rogers C, de Moissac YR, Knowles K, et al. Strain variation among Bordetella pertussis isolates from Quebec and Alberta provinces of Canada from 1985 to 1994. J Clin Microbiol 2003;41(7):3344-47.
27. Tsang RS, Sill ML, Martin IE, Jamieson F. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine. Can J Microbiol 2005;51:887-92.
28. Bromberg K. Pertussis. In: Hoperich PD, Jordan MC, Ronald AR (Eds.), Infectious Diseases: A Treatise of Infection Processes, Fifth Edition. Philadelphia, PA: JB Lippincott Company, 1994;393-97.
29. Pertussis. Vaccine Preventable Diseases. Public Health Agency of Canada (Winnipeg, MB). Available online at: http://www.phacaspc.gc.ca/im/ vpd-mev/pertussis_e.html (Accessed February 28, 2006).
30. He Q, Viljanen MK, Nikkaxi S, Lyytikainen R, Mertsola J. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J Infect Dis 1994;170:873-77.
31. Rosner B. Hypothesis testing: Person-time data. In: Fundamentals of Biostatistics, Fifth Edition. Pacific Grove, CA: Duxbury Press, 2000;677-741.